Patients with infection-related hospitalization may have increased risk for incident heart failure, including HFrEF and HFpEF.

Pfizer has made the decision to discontinue the clinical development program for danuglipron, an oral GLP-1 receptor agonist, being investigated for chronic weight management.

Researchers have found that patients with stage B heart failure characteristics and type 2 diabetes have impaired functional capacity.

Several hundred units of counterfeit Ozempic (semaglutide 1mg injection) were seized by the Food and Drug Administration.

More than 1700 pounds of butter are being recalled due to possible contamination with coliform, a type of bacteria found in fecal matter.

The FDA has cleared the Dexcom G7 15 Day continuous glucose monitoring system for individuals 18 years and older with ...

Nongenetic factors and rare genetic variants were sources of variation that could influence the association between age at menarche and CAD.

We explore the current guidance for osteoporosis screening in men, as well as barriers to access for both clinicians and ...

Glucocorticoid-induced adrenal insufficiency was lower in prevalence than previously estimated among patients with PMR or GCA.

Omission of breast surgery after neoadjuvant systemic therapy in select patients with invasive breast cancer may be feasible.

Community-level SDOH such as household income, neighborhood walkability, and healthcare access play a greater role in predicting THA outcomes than patient race.

Tirzepatide was associated with better glycemic control and weight loss outcomes than semaglutide and insulin among patients with T2D.